BRIEF- Viiv Healthcare files for European marketing approval for HIV drug

Fri Oct 25, 2013 8:12am EDT

Oct 25 (Reuters) - GlaxoSmithKline Plc : * Dolutegravir trii - EU regulatory submission * Viiv healthcare announces submission for single-tablet regimen of

dolutegravir combination for HIV * Viiv healthcare ltd has GlaxoSmithkline, Pfizer Inc, and Shionogi Limited as